UniProtKB/Swiss-Prot P01266: Variant p.Asp1312Gly

Thyroglobulin
Gene: TG
Feedback?

Variant information Variant position:

1312 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Aspartate (D) to Glycine (G) at position 1312 (D1312G, p.Asp1312Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and acidic (D) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs2069556 [ dbSNP | Ensembl ]

Sequence information Variant position:

1312 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

2768 The length of the canonical sequence.
Location on the sequence:

TQGHFQLQLPPGKMCSADYA D LLQTFQVFILDELTARGFCQ The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         TQGHFQLQLPPGKMCSADYADLLQTFQVFILDELTARGFCQ

Mouse                         TQAHFQLLLPPGKMCSVDYSGLLQAFQVFILDELIARGFCQ

Rat                           TQAHFQLLLPPGKMCSIDYSGLLQAFQVFILDELITRGFCQ

Pig                           TRGQFQLQLPPGKVCSADYAGLLPTFQVVILDELTARGFCR

Bovine                        TQAQFQLLLPLGKVCSADYSGLLLAFQVFLLDELTARGFCQ

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	20 – 2768	Thyroglobulin
Modified residue	1310 – 1310	Iodotyrosine
Modified residue	1310 – 1310	Thyroxine
Disulfide bond	1306 – 1356
Mutagenesis	1309 – 1309	D -> S. Abolishes thyroxine (T4) production.
Mutagenesis	1310 – 1310	Y -> F. Abolishes thyroxine (T4) production; when associated with F-24, F-2573 and F-2766.

Literature citations
Primary structure of human thyroglobulin deduced from the sequence of its 8448-base complementary DNA.
Malthiery Y.; Lissitzky S.;
Eur. J. Biochem. 165:491-498(1987)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); VARIANTS ASP-604; ASP-653; GLN-985 DEL; TYR-1043; THR-1059; GLY-1312; ARG-1437; HIS-1463; THR-1936; GLU-2091; LEU-2149; ARG-2170 AND HIS-2242; The revised 8307 base pair coding sequence of human thyroglobulin transiently expressed in eukaryotic cells.
van de Graaf S.A.R.; Pauws E.; de Vijlder J.J.M.; Ris-Stalpers C.;
Eur. J. Endocrinol. 136:508-515(1997)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); VARIANT GLY-1312; Genomic organization of the 5' region of the human thyroglobulin gene.
Moya C.M.; Mendive F.M.; Rivolta C.M.; Vassart G.; Targovnik H.M.;
Eur. J. Endocrinol. 143:789-798(2000)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1002-1566 (ISOFORM 1); VARIANT GLY-1312;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.